Terpineol

Terpineol

SCHEMBL5718779

CC1=CC[C@](O)(C(C)C)CC1

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 1/20 0.36
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
OPRK1 P41145 1/20 0.33
OPRL1 P41146 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Terpineol SCHEMBL17748829 1.00 STAT3 (0.36) STAT3OPRM1OPRD1OPRK1OPRL1
Terpineol SCHEMBL22344 1.00 STAT3 (0.36) STAT3OPRM1OPRD1OPRK1OPRL1
(-)-Terpinen-4-Ol SCHEMBL13180470 1.00 STAT3 (0.36) STAT3OPRM1OPRD1OPRK1OPRL1
Terpineol SCHEMBL8197135 1.00 STAT3 (0.36) STAT3OPRM1OPRD1OPRK1OPRL1
Terpineol SCHEMBL4540656 0.93 STAT3 (0.33) STAT3
SCHEMBL8626655 0.93 STAT3 (0.45) STAT3
SCHEMBL14828379 0.93 STAT3 (0.45) STAT3
Terpineol SCHEMBL15019941 0.91 STAT3 (0.33) STAT3
SCHEMBL6578134 0.81 STAT3 (0.31) STAT3
SCHEMBL23510525 0.80 STAT3 (0.30) STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117222327-A Methods of using formaldehyde-free antimicrobial compositions in animal byproduct compositions 伊士曼化工公司 2023-12-12 CN claimed
CN-114513960-A Antimicrobial composition for animal feed 塔明克私人有限公司 2022-05-17 CN claimed
US-20180360792-A1 Method of Treatment of Alopecia with Monoterpenoids Cellmid Limited (AU) 2018-12-20 US claimed
US-20160374979-A1 Method of Treatment of Alopecia with Monoterpenoids Cellmid Limited (AU) 2016-12-29 US claimed
CN-106061474-A Method of treatment of alopecia with monoterpenoids 赛尔米德有限公司 2016-10-26 CN claimed
WO-2025094121-A1 NATURAL DEEP EUTECTIC SYSTEMS THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) 2025-05-08 WO disclosed
US-20250107555-A1 UNIQUE BLEND OF PLANT-DERIVED COMPONENTS IN DRINKING WATER TO SUPPORT PIGLETS CAN TECHNOLOGIES, INC. (US) 2025-04-03 US disclosed
US-12253482-B2 Method for determining structure of substance in multicomponent sample KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2025-03-18 US disclosed
WO-2025034934-A1 UNIQUE BLEND OF PLANT-DERIVED COMPONENTS TO SUPPORT PIGLETS DURING NURSERY PHASE POST-WEANING CAN TECHNOLOGIES, INC. (US) 2025-02-13 WO disclosed
EP-4465826-A1 CELLULOSIC POLYMER-COATED GRANULES Eastman Chemical Company (US) 2024-11-27 EP disclosed
CN-118541033-A Cellulose polymer coated particles 伊士曼化工公司 2024-08-23 CN disclosed
EP-4319559-A1 METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS Eastman Chemical Company (US) 2024-02-14 EP disclosed
WO-2021085645-A1 METHOD FOR DETERMINING STRUCTURE OF SUBSTANCE IN MULTICOMPONENT SAMPLE キリンホールディングス株式会社 2021-05-06 WO disclosed
EP-3079679-B1 METHOD OF TREATMENT OF ALOPECIA WITH MONOTERPENOIDS CELLMID LTD (AU) 2019-08-14 EP disclosed
US-20180360792-A1 Method of Treatment of Alopecia with Monoterpenoids Cellmid Limited (AU) 2018-12-20 US disclosed
CN-105616179-B A kind of active factors COAWA of activation affinity interaction and its preparation and application 上海尚雪实业有限公司 2018-11-06 CN disclosed
CN-108291096-A Process for producing pellets comprising surface-reacted calcium carbonate 欧米亚国际集团 2018-07-17 CN disclosed
US-20160374979-A1 Method of Treatment of Alopecia with Monoterpenoids Cellmid Limited (AU) 2016-12-29 US disclosed
CN-106061474-A Method of treatment of alopecia with monoterpenoids 赛尔米德有限公司 2016-10-26 CN disclosed
EP-1185178-B1 INSECTICIDAL COMPOSITIONS HERBAL SCIENCES INTERNAT LTD (GB) 2006-10-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160374979-A1 Method of Treatment of Alopecia with Monoterpenoids FGF1, FGF2, FGFR1 STAT3 531/4885OPRM1 4817/4885OPRD1 4701/4885
US-20180360792-A1 Method of Treatment of Alopecia with Monoterpenoids FGF1, FGF2, FGFR1 STAT3 542/4885OPRM1 4822/4885OPRD1 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.